title: Resveratrol protects human lens epithelial cells against H2O2-induced oxidative stress by increasing catalase, SOD-1, and HO-1 expression.
abstract: OBJECTIVE
  Oxidative damage induced by H(2)O(2) treatment can irreversibly damage the lens epithelium, resulting in cell death and cataract. Whether the effects of oxidative stress could be attenuated in cultured human lens epithelial cells by incubation with resveratrol (RES) is still unknown. In the present study, we examined the function of resveratrol in protecting human lens epithelial B-3 (HLEB-3) cells against H(2)O(2) induced cell death and cell apoptosis, its role in reducing H(2)O(2) induced intracellular reactive oxygen species (ROS) accumulation, and investigated the mechanism by which resveratrol underlies the effect.
  
  
  METHODS
  HLEB-3 cells, a human lens epithelial cell line, were exposed to 100 muM H(2)O(2) with or without RES pre-treatment at different concentrations for different time duration. Cell viabilities were monitored by 4-[3-[4-iodophenyl]-2-4(4-nitrophenyl)-2H-5-tetrazolio-1,3-benzene disulfonate] (WST-1) assay. The apoptosis rate and ROS generation were detected by flow cytometric analysis. Expression levels of superoxide dismutases-1 (SOD-1), catalase, and heme oxygenase-1 (HO-1) proteins were measured by western-blotting analysis. p38 and c-jun N terminal kinase (JNK) activation was also evaluated by western-blotting analysis.
  
  
  RESULTS
  Resveratrol clearly reduced H(2)O(2) induced cell apoptosis and ROS accumulation; protected HLEB-3 cells from H(2)O(2) induced oxidative damage, and increased the expression levels of SOD-1, catalase, and HO-1. Further studies showed that RES also inhibited H(2)O(2) induced p38 and JNK phosphorylation.
  
  
  CONCLUSIONS
  These findings suggested that RES protected HLEB-3 cells from H(2)O(2) induced oxidative damage, presumably by inducing three antioxidative enzymes including catalase, SOD-1, and HO-1.
authors.affiliation: Department of Ophthalmology, The First Affiliated Hospital of Harbin Medical University, Harbin, PR China.
authors.forename: Yi
authors.initials: Y
authors.lastname: Zheng
authors.forename: Yaohua
authors.initials: Y
authors.lastname: Liu
authors.forename: Jinying
authors.initials: J
authors.lastname: Ge
authors.forename: Xiaoyuan
authors.initials: X
authors.lastname: Wang
authors.forename: Lijuan
authors.initials: L
authors.lastname: Liu
authors.forename: Zhigao
authors.initials: Z
authors.lastname: Bu
authors.forename: Ping
authors.initials: P
authors.lastname: Liu
mesh_terms: D017209:Apoptosis / Q000187:drug effects; D002374:Catalase / Q000378:metabolism; D002460:Cell Line; D019610:Cytoprotection / Q000187:drug effects*; D004847:Epithelial Cells / Q000166:cytology* / Q000187:drug effects / Q000201:enzymology*; D051547:Heme Oxygenase-1 / Q000378:metabolism; D006801:Humans; D006861:Hydrogen Peroxide / Q000494:pharmacology*; D048031:JNK Mitogen-Activated Protein Kinases / Q000378:metabolism; D007908:Lens, Crystalline / Q000166:cytology*; D018384:Oxidative Stress / Q000187:drug effects*; D010766:Phosphorylation / Q000187:drug effects; D000077185:Resveratrol; D013267:Stilbenes / Q000494:pharmacology*; D013482:Superoxide Dismutase / Q000378:metabolism; D000072105:Superoxide Dismutase-1; D015854:Up-Regulation / Q000187:drug effects; D048051:p38 Mitogen-Activated Protein Kinases / Q000378:metabolism
chemical_list: C000606290:SOD1 protein, human; D013267:Stilbenes; D006861:Hydrogen Peroxide; D002374:Catalase; D051547:Heme Oxygenase-1; D013482:Superoxide Dismutase; D000072105:Superoxide Dismutase-1; D048031:JNK Mitogen-Activated Protein Kinases; D048051:p38 Mitogen-Activated Protein Kinases; D000077185:Resveratrol
references.citation: FEBS Lett. 1999 May 14;451(1):63-7
references.pmid: 10356984
references.citation: Exp Eye Res. 2005 May;80(5):709-25
references.pmid: 15862178
references.citation: Adv Exp Med Biol. 1999;472:115-30
references.pmid: 10736621
references.citation: Crit Rev Food Sci Nutr. 2002;42(3):209-21
references.pmid: 12058980
references.citation: Int Rev Exp Pathol. 1991;32:223-54
references.pmid: 1677933
references.citation: Biomed Pharmacother. 1999 May;53(4):165-7
references.pmid: 10392288
references.citation: Cell Signal. 2000 Jan;12(1):1-13
references.pmid: 10676842
references.citation: Res Commun Mol Pathol Pharmacol. 2001 Mar-Apr;109(3-4):165-97
references.pmid: 11758648
references.citation: Surv Ophthalmol. 2000 Sep-Oct;45(2):115-34
references.pmid: 11033038
references.citation: J Ocul Pharmacol Ther. 2000 Apr;16(2):121-35
references.pmid: 10803423
references.citation: FASEB J. 2003 Nov;17(14):1975-85
references.pmid: 14597667
references.citation: Int J Oncol. 2003 Jul;23(1):17-28
references.pmid: 12792772
references.citation: Free Radic Biol Med. 2006 Nov 1;41(9):1425-32
references.pmid: 17023269
references.citation: J Biol Chem. 2003 May 16;278(20):18207-13
references.pmid: 12646558
references.citation: Pharmacol Toxicol. 2000 May;86(5):203-8
references.pmid: 10862501
references.citation: Cancer Lett. 2002 Jan 25;175(2):165-73
references.pmid: 11741744
references.citation: Mutat Res. 2001 Sep 20;496(1-2):181-90
references.pmid: 11551494
references.citation: Vet Ophthalmol. 2006 Sep-Oct;9(5):292-8
references.pmid: 16939456
references.citation: Exp Eye Res. 2005 Sep;81(3):276-85
references.pmid: 16129095
references.citation: Exp Eye Res. 1985 Feb;40(2):213-22
references.pmid: 3979462
references.citation: J Cell Biol. 1995 Jul;130(1):169-81
references.pmid: 7790371
references.citation: FASEB J. 1995 Sep;9(12):1173-82
references.pmid: 7672510
references.citation: Invest Ophthalmol Vis Sci. 2001 Dec;42(13):3247-55
references.pmid: 11726630
references.citation: Ophthalmologica. 2000 Jan-Feb;214(1):78-85
references.pmid: 10657746
references.citation: Cancer Res. 2001 Feb 15;61(4):1604-10
references.pmid: 11245472
references.citation: Exp Eye Res. 1994 Feb;58(2):207-18
references.pmid: 8157113
references.citation: Biochem Biophys Res Commun. 1998 Sep 8;250(1):53-8
references.pmid: 9735330
references.citation: Am J Physiol Heart Circ Physiol. 2007 May;292(5):H2417-24
references.pmid: 17220179
references.citation: Am J Physiol Heart Circ Physiol. 2001 Nov;281(5):H1976-84
references.pmid: 11668058
references.citation: Carcinogenesis. 2000 Nov;21(11):1965-9
references.pmid: 11062155
references.citation: Environ Health Perspect. 1994 Dec;102 Suppl 10:5-12
references.pmid: 7705305
references.citation: Int Ophthalmol Clin. 2005 Winter;45(1):141-55
references.pmid: 15632531
references.citation: Proc Natl Acad Sci U S A. 1997 Feb 4;94(3):884-9
references.pmid: 9023351
references.citation: Cell. 2000 Oct 13;103(2):239-52
references.pmid: 11057897
references.citation: Invest Ophthalmol Vis Sci. 2003 Dec;44(12):5383-95
references.pmid: 14638742
references.citation: Exp Mol Med. 2000 Jun 30;32(2):88-92
references.pmid: 10926121
references.citation: Chem Biol Interact. 2005 Jan 15;151(2):143-9
references.pmid: 15698585